C11H14N4O5S
Neat
314.32
194241-83-3; Ceftazidime impurity G [EP]; UNII-VF63LFC0D8; VF63LFC0D8; Ceftazidime specified impurity G [EP]; Ceftazidime pentahydrate impurity G [EP]; 2-((((1Z)-1-(2-Aminothiazol-4-yl)-2-((oxoethyl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid; DTXSID60173047; Propanoic acid, 2-(((Z)-(1-(2-amino-4-thiazolyl)-2-oxo-2-((2-oxoethyl)amino)ethylidene)amino)oxy)-2-methyl; CEFTAZIDIME IMPURITY G [EP IMPURITY]; CEFTAZIDIME PENTAHYDRATE IMPURITY G [EP IMPURITY]; CEFTAZIDIME IMPURITY G (EP IMPURITY); Ceftazidime Impurity G; CEFTAZIDIME PENTAHYDRATE IMPURITY G (EP IMPURITY); RefChem:83610; Ceftazidime specified impurity G; DTXCID6095538; Ceftazidime pentahydrate impurity G; Ceftazidime EP Impurity G; 2-[(Z)-[1-(2-amino-1 and 3-thiazol-4-yl)-2-oxo-2-(2-oxoethylamino)ethylidene]amino]oxy-2-methylpropanoic acid
2-[(Z)-[1-(2-amino-1 and 3-thiazol-4-yl)-2-oxo-2-(2-oxoethylamino)ethylidene]amino]oxy-2-methylpropanoic acid
InChI=1S/C11H14N4O5S/c1-11(2,9(18)19)20-15-7(8(17)13-3-4-16)6-5-21-10(12)14-6/h4-5H,3H2,1-2H3,(H2,12,14)(H,13,17)(H,18,19)/b15-7-